9/13/2018Two Underwhelming China Tech IPOs in NY Spell Trouble for Those in Lin...

9/13/2018BioCad and Shanghai Pharma Sign MOU for Two JVs

9/13/2018EU Regulators Issue Notice on a Chinese Anticancer API After Rejected ...

9/13/2018Phase II of HKEx Biotech Experiment Begins with Cautious Hua Medicine ...

9/13/2018Novocure and Zai Lab Announce Partnership & License Deal for Tumor...

9/13/2018Athenex and Hanmi Pharma Realign Their Joint Projects

9/13/2018Allergan and AliHealth to Launch Digital Platform for Medical Aestheti...

9/12/2018Tasly Licenses US Rights of TCM Angina Drug to Arbor Pharma in $50M De...

9/11/2018SMIA’s Official Responsibilities and Internal Organization Approved

9/11/2018NMPA's Official Responsibilities and Internal Organization Approved

9/11/2018SAMR's Official Responsibilities and Internal Organization Approved

9/11/2018NHC's Official Responsibilities and Internal Organization Approved

9/11/2018Snapshot of Chinese Public Hospital Vaccine Consumption 2017

9/11/2018CDE Publicizes Batch 32 of Drug Applications To Be Granted Priority Re...

9/11/2018WuXi Biologics and Inhibrx Enter an Exclusive Partnership for GMP Manu...

9/11/2018Innovent Receives Chinese IND Approval for mAb Drug Candidate

9/11/2018China CDMO Market 2018-2021: The R&D Cost of New Drugs Continues t...

9/10/2018NMPA Issues New Announcement (2018#64) for Clinical Data Self-Inspecti...

9/10/2018The TKI Lung Cancer Market in China

9/7/2018Recent Executive Moves

9/7/2018Luye Pharma's Prostate Cancer Drug Initiates Phase III Clinical Trials...

9/7/2018Hansoh Pharma Applies for Hong Kong IPO

9/7/2018Nearly 90% of Listed Biopharma Cos Saw their Sales Expenditures Up in ...

9/7/2018Astellas Launches Its OAB Drug Myrbetriq (mirabegron) in China

9/7/2018NMPA Suspends Sales and Use of Dr. Reddy’s Quetiaping Fumarate Follow...

9/7/2018NMPA Solicits Comments on Draft Guidelines on Collection and Reporting...

9/7/2018NMPA Withdraws Approvals of Six Drugs Including Four Import Drugs

9/6/2018Eisai and MSD Announce NMPA Approval of HCC Drug LENVIMA

9/5/2018NMPA Approves Alexion's Orphan Drug Soliris (Eculizumab)

9/5/2018CDE Seeks Comments on Draft ICH Guideline M9: Guideline on BCS-Based B...

Page:325/789 Total number of articles:23668: [First][<<] [323] [324] [325] [326] [327] [>>] [End]